Patents Assigned to Sofotec GmbH & Co. KG
-
Patent number: 8051851Abstract: In order to improve the security and reliability of administration of powdered pharmaceuticals through dry powder inhalers, the invention proposes an inhaler (1) for powdered medicaments, comprising an activating device (4) for manual engagement by the patient for repeatedly metering a dose of medicament to be administered to the patient, and further comprising an advancing mechanism (25) for advancing a counter or indexing means (8) each time the activating device (4) has been engaged by the patient so that a dose of medicament has been released for administration to the patient, wherein the counter or indexing means (8) comprises an index (9), the index (9) being detectable by a detection means (10) of the inhaler, and the detection means (10) being coupled to a locking mechanism (12), the locking mechanism (12) blocking the activating device (4) and/or any transportation mechanism (5) of the inhaler (1) delayed by a predetermined number of metering cycles since detection of the index (9), and a cartridge (Type: GrantFiled: July 18, 2005Date of Patent: November 8, 2011Assignee: Sofotec GmbH & Co. KGInventors: Martin Herder, Ingo Mett, Joachim Goede
-
Patent number: 7258118Abstract: To improve administration of powdered pharmaceuticals, a pharmaceutical powder cartridge (1) for powder inhalers for holding a pharmaceutical depot for a large number of pharmaceutical powder doses is proposed, having at least one storage space (6) and an integrated metering device, said integrated metering device comprising at least one metering slide (9, 13, 14) which can be moved approximately transversely in a metering slide channel (12) at least from a filling position to an emptying position, approximately transversely with respect to the direction of flow of the pharmaceutical powder out from the at least one storage space (6), said metering slide channel (12) with the at least one metering slide (9, 13, 14) being sealed off from the environment at least in the filling position of the metering slide (9, 13, 14), and also further measures and a corresponding inhaler.Type: GrantFiled: January 22, 2003Date of Patent: August 21, 2007Assignee: Sofotec GmbH & Co, KGInventors: Joachim Goede, Martin Herder, Karl-Heinz Lange, Meike Eilbracht
-
Patent number: 7253182Abstract: Disclosed are enantiomerically pure cyclic aminoalcohol esters of arylcycloalkylhydroxycarboxylic acids with at least 90% enantiomeric excess of the (3R,2?R), (3S,2?R), (3R,2?S), or (3S,2?S) configured enantiomer.Type: GrantFiled: June 23, 2003Date of Patent: August 7, 2007Assignee: Sofotec GmbH & Co. KGInventors: Christian Noe, Ernst Mutschler, Günter Lambrecht, Ruth Irene Elgert, legal representative, Sittah Czeche, Magali Waelbroeck, Michael Elgert, deceased
-
Publication number: 20060251589Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.Type: ApplicationFiled: July 13, 2006Publication date: November 9, 2006Applicant: Sofotec GmbH & Co. KGInventors: Joachim Maus, Peter Cnota, Istvan Szelenyi, Beatrix Fyrnys
-
Publication number: 20060252815Abstract: The present invention describes a combination of anticholinergic and ? mimetics for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma. It further comprises the preparation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.Type: ApplicationFiled: July 11, 2006Publication date: November 9, 2006Applicant: Sofotec GmbH & Co. KGInventors: Joachim Goede, Joachim Maus, Peter Cnota, Istvan Szelenyi
-
Publication number: 20060037612Abstract: In order to improve the security and reliability of administration of powdered pharmaceuticals through dry powder inhalers, the invention proposes an inhaler (1) for powdered medicaments, comprising an activating device (4) for manual engagement by the patient for repeatedly metering a dose of medicament to be administered to the patient, and further comprising an advancing mechanism (25) for advancing a counter or indexing means (8) each time the activating device (4) has been engaged by the patient so that a dose of medicament has been released for administration to the patient, wherein the counter or indexing means (8) comprises an index (9), the index (9) being detectable by a detection means (10) of the inhaler, and the detection means (10) being coupled to a locking mechanism (12), the locking mechanism (12) blocking the activating device (4) and/or any transportation mechanism (5) of the inhaler (1) delayed by a predetermined number of metering cycles since detection of the index (9), and a cartridge (Type: ApplicationFiled: July 18, 2005Publication date: February 23, 2006Applicant: Sofotec GmbH & Co. KGInventors: Martin Herder, Ingo Mett, Joachim Goede
-
Publication number: 20050222102Abstract: The present invention provides novel combinations comprising a topical anticholinergic drug alone or in combination with topically administered antihistamines, topically or orally administered phosphodiesterase 4 inhibitors or topical corticosteroids for the treatment of rhinitis of various origins. It further comprises presentation of these combinations in locally applied formulations and includes various pharmaceutical formulations suitable for topical application, e.g. nasal sprays, nasal drops, emulsions, pastes, creams and gels.Type: ApplicationFiled: February 7, 2005Publication date: October 6, 2005Applicant: Sofotec GmbH & Co. KGInventors: Joachim Maus, Ursula Petzold, Istvan Szelenyi, Torsten Hoffmann, Mario Weingart
-
Publication number: 20050175547Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.Type: ApplicationFiled: February 7, 2005Publication date: August 11, 2005Applicant: Sofotec GmbH & Co. KGInventors: Joachim Maus, Peter Cnota, Istvan Szelenyi, Beatrix Fyrnys
-
Publication number: 20050175549Abstract: The present invention describes a combination of anticholinergic and ? mimetics for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma. It further comprises the preparation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.Type: ApplicationFiled: February 7, 2005Publication date: August 11, 2005Applicant: Sofotec GmbH & Co. KGInventors: Joachim Goede, Joachim Maus, Peter Cnota, Istvan Szelenyi
-
Publication number: 20050175548Abstract: The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive component or underlying inflammation like asthma and chronic obstructive pulmonary disease (COPD). It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.Type: ApplicationFiled: February 7, 2005Publication date: August 11, 2005Applicant: Sofotec GmbH & Co. KGInventors: Joachim Goede, Joachim Maus, Peter Cnota, Istvan Szelenyi
-
Patent number: 6681768Abstract: A disperser for dry powders which can be used with different dose systems, dose weights ranging from 2 to 25 mg and different types of powder formulation. In one embodiment, the disperser acts both as a de-agglomeration (disintegration; aerosolization) means and as an air classifier for especially adhesive mixtures. Only fine drug particles are emitted whereas the larger agglomerates and carrier crystals are retained by the disperser. Another embodiment enables time controlled release of carrier crystals in these mixtures. Yet another embodiment has optimized performance with spherical pellets, containing no carrier crystals. Other possible embodiments of the invention make it possible to control the total inhaler resistance and the powder deposition in the upper respiratory tract by means of the addition of a so-called sheath flow of clean air. Modifications also enable carrier retainment in the mouthpiece and elimination of the tangential flow component of the discharge cloud.Type: GrantFiled: June 21, 2002Date of Patent: January 27, 2004Assignee: Sofotec GmbH & Co. KGInventors: Anne Haaije de Boer, Henderik Willem Frijlink, Doetie Gjaltema, Joachim Goede, Paul Hagedoorn